Reply: Premature ovarian insufficiency and the risk of breast cancer
Open Access
- 7 March 2025
- journal article
- Published by Oxford University Press (OUP) in Human Reproduction Open
- Vol. 2025 (2) , hoaf018
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Hormone replacement therapy and the risk of endometrial cancer: A systematic reviewMaturitas, 2016
- Impact of Premature Ovarian Failure on Mortality and Morbidity among Chinese WomenPLOS ONE, 2014
- Progestogens Used in Postmenopausal Hormone Therapy: Differences in Their Pharmacological Properties, Intracellular Actions, and Clinical EffectsEndocrine Reviews, 2012
- Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studiesThe Lancet Oncology, 2012
- Hormone therapy in postmenopausal women and risk of endometrial hyperplasiaCochrane Database of Systematic Reviews, 2012
- Risk of gynecological cancers in users of estradiol/dydrogesterone or other HRT preparationsClimacteric, 2009
- Modification of Ovarian Cancer Risk by BRCA1/2-Interacting Genes in a Multicenter Cohort of BRCA1/2 Mutation CarriersCancer Research, 2009
- Are the progestins responsible for breast cancer risk during hormone therapy in the postmenopause?The Journal of Steroid Biochemistry and Molecular Biology, 2008
- Increased risk of breast cancer following different regimens of hormone replacement therapy frequently used in EuropeInternational Journal of Cancer, 2004
- Early age at menopause and breast cancer: are leaner women more protected? A prospective analysis of the Dutch DOM cohortBreast Cancer Research and Treatment, 1999